Patents by Inventor Stefan Lyer

Stefan Lyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMOBILIZATION AND MAGNETIC EXTRACTION OF PATHOGENS AND PATHOGEN COMPONENTS
    Publication number: 20240125775
    Abstract: Immobilization and magnetic extraction of pathogens and pathogen components The application describes a method for reducing the concentration of pathogens and/or pathogen components in an aqueous or body fluid sample. Specifically, the method relates to incubating the sample with superparamagnetic iron-based particles attached to a target binding peptide and immobilising the superparamagnetic iron-based particles with a magnetic field and thereby separating the pathogen-bound and/or pathogen component-bound superparamagnetic iron-based particles from the sample. Furthermore, the application relates to a method for identifying pathogens in an aqueous or body fluid sample a use of superparamagnetic iron-based particles for reducing the concentration of pathogens and/or pathogen components in an aqueous or body fluid sample. In addition, a use of superparamagnetic iron-based particles for identifying pathogens in an aqueous or body fluid sample is disclosed.
    Type: Application
    Filed: November 25, 2021
    Publication date: April 18, 2024
    Applicant: FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG
    Inventors: Christoph ALEXIOU, Stefan LYER, Rainer TIETZE, Bernhard FRIEDRICH
  • Use of DMBT1 for capturing sulphate and phosphate group exposing agents
    Patent number: 8017124
    Abstract: Disclosed is the use of DMBT1, or of the nucleic acid encoding it, for the manufacture of a medicament for the treatment of a patient suffering from a disease caused by an agent, which possesses at least one accessible sulphate and/or at least one accessible phosphate group, uses of DMBT1 as a diagnostic for diagnosing the susceptibility of an individual to sulphate or phosphate groups, as well as methods for diagnosis, prophylaxis or treatment of diseases caused by an agent which possesses at least one accessible sulphate and/or at least one accessible phosphate group.
    Type: Grant
    Filed: February 25, 2005
    Date of Patent: September 13, 2011
    Assignee: Deutsches Krebsforschungszentrum
    Inventors: Jan Mollenhauer, Caroline End, Stephanie Blaich, Gaby Bergmann, Marcus Renner, Stefan Lyer, Rainer Wittig, Annemarie Poustka, Floris Bikker, Antoon Ligtenberg, Arie Nieuw-Amerongen, Enno Veerman
  • Use of Dmbt1 for Capturing Sulphate and Phosphate Group Exposing Agents
    Publication number: 20080234185
    Abstract: Disclosed is the use of DMBT1, or of the nucleic acid encoding it, for the manufacture of a medicament for the treatment of a patient suffering from a disease caused by an agent, which possesses at least one accessible sulphate and/or at least one accessible phosphate group, uses of DMBT1 as a diagnostic for diagnosing the susceptibility of an individual to sulphate or phosphate groups, as well as methods for diagnosis, prophylaxis or treatment of diseases caused by an agent which possesses at least one accessible sulphate and/or at least one accessible phosphate group.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 25, 2008
    Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM
    Inventors: Jan Mollenhauer, Caroline End, Stephanie Blaich, Gaby Bergmann, Marcus Renner, Stefan Lyer, Rainer Wittig, Annemarie Poustka, Floris Bikker, Antoon Ligtenberg, Arie Nieuw-Amerongen, Enno Veerman